← Leaderboards
Subhra Chakraborty
Johns Hopkins University
$7,655,819
Attributed
$10,053,837
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,053,837 · 6
By mechanism
R01$7,422,628 · 2
U01$1,167,741 · 1
R56$1,095,030 · 2
R21$368,438 · 1
Top collaborators
- Robert H Gilman6 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert H Gilman$35,342,766
- David A Sack$10,059,713
- Alison Turnbull$2,388,365
- Holly C Wilcox$5,445,929
- Mark Donowitz$42,405,980
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionFecesChildDiarrheaMorbidity - Disease RateLifeKineticsLengthCollaborationsHospitalizationBirthDetectionPeruCohort StudiesCostSymptomsCountryMalnutritionBloodFutureDiagnostic TestsLaboratoriesEnrollmentBlood Specimen
Grant awards (17)
The impact of shigellosis and recommended treatment in children$762,838
U01 · FY2025 · AI · contact PI
The impact of non-dysentery Shigella-associated diarrhea in children$722,477
R01 · FY2025 · AI · contact PI
The impact of shigellosis and recommended treatment in children$209,753
U01 · FY2025 · AI · contact PI
The impact of shigellosis and recommended treatment in children$195,150
U01 · FY2025 · AI · contact PI
The impact of non-dysentery Shigella-associated diarrhea in children$741,264
R01 · FY2024 · AI · contact PI
Maternally acquired immunity in protection against enterotoxigenic E. coli infections in infants$571,071
R56 · FY2024 · AI · contact PI
The impact of non-dysentery Shigella-associated diarrhea in children$665,901
R01 · FY2023 · AI · contact PI
The impact of non-dysentery Shigella-associated diarrhea in children$661,267
R01 · FY2022 · AI · contact PI
The impact of non-dysentery Shigella-associated diarrhea in children$406,753
R01 · FY2021 · AI · contact PI
The impact of non-dysentery Shigella-associated diarrhea in children$523,959
R56 · FY2020 · AI · contact PI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$1,056,841
R01 · FY2019 · AI
A novel diagnostic tool to aid vaccine evaluation and surveillance of enterotoxigenic E. coli and Shigella$163,750
R21 · FY2019 · AI · contact PI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$1,066,175
R01 · FY2018 · AI
A novel diagnostic tool to aid vaccine evaluation and surveillance of enterotoxigenic E. coli and Shigella$204,688
R21 · FY2018 · AI · contact PI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$1,075,705
R01 · FY2017 · AI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$641,504
R01 · FY2016 · AI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$384,741
R01 · FY2016 · AI